Growing prevalence of chronic such as cancer, cardiovascular diseases (CVD), and central nervous system (CNS) disorders is making a promising impact on the demand for applications of gene therapy across the globe. Existing cancer therapies such as chemo and radiation therapies and the prescribed drugs have resulted in many side effects that can include internal damage to the organs. Additionally, the higher costs of cancer diagnosis procedures, increase in awareness towards gene therapy products for the treatment of various diseases, and government support to promote gene therapy-related research are the major influencing factors that are anticipated to boost the market growth. Cancer is a major cause of death around the world, accounted for about 9.6 million deaths in 2018, as per the World Health Organization. Growing occurrence of inherited and neurological disorders and an increasing urgency to treat these diseases in less time are the key factors fuelling the growth of the gene therapy market. The global gene therapy market size is evaluated at $710 million as of 2018 and is anticipated to grow with a CAGR of 31.5% throughout the forecast period 2019-2025. The report covers Gene Therapy Market size by development phase and applications, Gene Therapy Market share by top 5 companies and also the market share by start-ups during the forecast period.
View Full Table of Contents of Gene Therapy Market:
https://www.industryarc.com/Report/15868/gene-therapy-market.html
Report Price (Single User): US $3850
According to the WHO, approximately 47.5 million people are suffering from dementia cases every year, globally. Alzheimer’s disease is a common form of dementia, which constitutes about 60-70 % of total cases. Neurological disorders, such as motor neuron disease, Parkinson’s, and Alzheimer’s diseases, can be treated by advanced gene therapy solutions efficiently. For instance, ProSavin, lentiviral vector-based gene therapy for Parkinson’s disease, which is caused by dopamine deficiency in the brain. ProSavin delivers into the brain and stimulates the target cells to begin dopamine production.
Diseases Potentially Treated by Gene Therapy
Inherited Diseases
For people with inherited diseases, gene therapy could replace a defective or missing gene or express a missing biological factor, enzyme or protein. Hemophilia, cystic fibrosis, and inherited retinal degeneration are some of the inherited diseases being treated by gene therapy technique. Replacement of a defective or dysfunctional gene altogether with the therapeutic gene is the exceptional benefit that is promoting the progress of the gene therapy marketplace.
Hemophilia
A bleeding disorder caused by the deficiency of the coagulation factor due to mutations in the genes. According to NCBI, in the United States, approximately 60% of the adults report adherence to prophylaxis due to its inherent complexity, resulting in unacceptable rates of bleeding disorders. Conventional therapy requires regular intravenous infusions of the missing coagulation proteins into the patients’ body.
Cystic Fibrosis
A genetic disorder that causes severe damage to the intestinal system and lungs. It majorly affects mucus, digestive juices, and sweat-producing cells. When there is an alteration or mutation in the genetic instructions, the production of the cystic fibrosis transmembrane conductance regulator (CFTR) gene may be affected. The CFTR protein has been cloned, and researchers are now developing gene therapies to enable the expression of CFTR.
Inherited Retinal Degeneration
Ocular gene therapies could offer a treatment for people with inherited retinal degeneration. Defects in the genes expressed in the retinal pigment epithelial cells may result in retinal degeneration. For instance, Luxturna is the first gene therapy molecule for an inherited genetic disease ever. It was developed by Spark Therapeutics and approved by the FDA in December 2017, for the United States. Luxturna is used for patients with an inherited form of retinal dystrophy, and it is injected directly into the retina of the patients so it can infect the retinal cells.
Infectious Diseases
Gene therapy vaccines are being developed and are under clinical trials for tackling infectious diseases, including malaria, tuberculosis, HIV, and influenza. Tuberculosis vaccines are being studied that use genetically modified vaccine comprising a recombinant fowlpox virus and a modified vaccine virus Ankara (MVA), each containing a tuberculosis antigen. Malaria vaccines are undergoing clinical trials utilize Chimpanzee adenovirus containing malaria antigen.
Latest Gene Therapy Products on Market
China is the first country that has approved and introduced commercial gene therapy molecules for the treatment of several chronic disorders into the market. The first product in this pipeline is Gendicine for the treatment of head and neck squamous cell carcinoma, and in the western world, the first approved gene therapy product was Glybera for the treatment of pancreatitis. In February 2019, scientists that working with Sangamo Therapeutics, an American biotechnology company has announced the first-ever in body human gene editing therapy to permanently alter DNA in a patient with Hunter Syndrome which causes severe abnormalities in many organs such as respiratory system, heart, and skeleton. Furthermore, in August 2017, the USFDA approved Novartis AG’s gene therapy molecule, Kymriah, for the treatment of B-cell precursor acute lymphoblastic leukemia (ALL) in children and adults up to the age of 25 years. In May 2016, GlaxoSmithKline, a British pharmaceutical company introduced a stem cell gene therapy product, Strimvelis, for the treatment of patients with severe combined immunodeficiency, due to adenosine deaminase deficiency (ADA-SCID).
North America Holding Major Share of the Gene Therapy Market
North America generated approximately 40% of the global revenue in the gene therapy market in 2018. Most of the companies in the U.S. are seeking approvals from the concerned authorities for the next phase of clinical trials, and gene therapy molecules are arranged for commercial usage. FDA has approved 3 gene therapy molecules to treat cancer and inherited blindness diseases in 2018 alone. This region is anticipated to witness significant growth in the upcoming years owing to the high occurrence of cancer cases. For instance, according to a report published in the American Cancer Society’s journal, 6,09,640 cancer deaths were reported in the U.S. in 2018. Supportive initiatives by local governments and companies to promote R&D activities in the healthcare sector can stimulate regional market expansion. For instance, in 2018, the U.S government approved US$ 3 billion for the National Institutes of Health (NIH) research funding. Rising cases of diffuse large B-cell lymphoma (DLBCL) in the United States are likely to impel the demand for chimeric antigen receptor (CAR) T-cell therapy. Yescarta is the first CAR T-cell therapy approved by the U.S. food and drug administration (FDA) for the treatment of large B-cell lymphoma.
The application segment that will be creating the most lucrative opportunities for the gene therapy market is oncology. This application segment is projected to grow at a CAGR of 18.5% through to 2025. According to the National Center for Biotechnology Information, the progression in oncology study and treatment of tumor expenses is forecast to rise 7-10% annually throughout 2020, with a total cost exceeding $150 billion. Increased application of gene therapy products in the treatment of other forms of cancers is poised to drive the oncology segment during the forecast period. Viral Oncological disorders are the largest contributor toward the market growth owing to the high prevalence of cancer worldwide and the availability of regulatory approved gene therapy for cancer.
Talk to one of our sales representative about the full report by providing your details in the link below:
https://www.industryarc.com/support.php?id=15868
The Major Players in the Gene Therapy Market:
The prominent players in the gene therapy market include Adaptimmune, BioCancell, Bluebird bio, Inc., Celgene, GlaxoSmithKline, Merck, OncoGenex Pharmaceuticals, Shanghai Sunway Biotech, Shenzhen SiBiono GeneTech, and SynerGene Therapeutics.
In January 2019, Bristol-Myers Squibb Company announced that it would acquire Celgene Corporation. This agreement would result in the formation of a specialty-focused biopharmaceutical company that can address the patient needs through high-value innovative medicines.
Related Reports:
A. Regenerative Medicine Market
https://www.industryarc.com/Report/16223/regenerative-medicine-market.html
B. Genomics Market
https://www.industryarc.com/Report/1275/genomics-market-analysis-and-forecast-report.html
About IndustryARC:
IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.
Contact Info:
Name: Venkat Reddy
Email: Send Email
Organization: IndustryARC
Phone: (+1) 614-588-8538
Website: https://www.industryarc.com/Domain/8/lifesciences-healthcare-market-research.html
The global Gene Therapy Market is estimated to grow at a CAGR of 24%, during the forecast period 2021-2027, according to a recently published report by Astute Analytica.
The report provides a comprehensive analysis of segments in the Gene Therapy market, covering all the major regions and countries.
The major regions analyzed in the study are North America, Europe, Asia Pacific, South America, and Middle East & Africa.
The report also includes additional information related to key market determinants such as trends, drivers, challenges, and restraints that hinders the overall market growth with an overview for each mentioned segment in the study.
Request a Sample of this report @ https://www.astuteanalytica.com/request-sample/gene-therapy-marketKey market segments of the Gene Therapy Market are:By IndicationCancerCardiovascular DiseasesHepatological DiseasesInfectious DiseaseNeurological DisordersOncological DisordersRare DiseasesOthers Diseases and DisordersBy Vector TypeViralAdenovirusAdeno-associated VirusHerpes Simplex VirusLentivirusPoxvirusRetrovirusVaccinia VirusOthersNon-viralElectroporationGene GunNaked Plasmid VectorLipofectionOthersBy Gene TypeAntigenCytokineDeficiencyGrowth FactorsReceptorsSuicide GeneTumour SuppressorOthersBy Method of DeliveryEx-vivoIn-vivoRegional Analysis Asia PacificNorth AmericaEuropeSouth AmericaMiddle East & AfricaThe research study offers a detailed regional analysis of global market scenarios, by including current market trends and future forecasts.
The study also offers an in-depth analysis of major driving factors, market segments, regional and country-level analysis, and key players present in the market.
The Global Gene Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.Gene therapy includes use of DNA as a pharmaceutical agent to treat diseases.
It promises to be one of the most important frontiers in medicine and a promising treatment option for a number of diseases (including inherited disorders, some types of cancer, and certain viral infections).
In the recent scenario, various pharmaceutical companies are using clinical data to validate the concept of gene therapy.
Moreover, many venture capital investors are also showing their interest in gene therapy, and are investing heavily in its development.The growth is attributed to development in the gene silencing technology, increasing demand for gene therapy in immunodeficiency syndromes, growing popularity of DNA vaccines, and development in the nanotechnology.
However, stringent regulatory laws in U.S. and Europe for gene therapy, side effects of gene therapy, Occurrence of Multigene Disorders in Gene Therapy and technical limitations are hindering the growth of this market.Final Report will cover the impact of COVID-19 on this industry.Browse the complete Global Gene Therapy Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/412-gene-therapy-market-reportThe key players in this market are:AnGes MG, IncArk TherapeuticsCeregene, IncCobra BiologicsGenVec, IncGenzyme CorporationVical, IncOxford BioMedicaBioSante PharmaceuticalsShenzhen SiBiono GeneTech Co., LtdTransgeneSEGMENTATIONS IN REPORT:By TypeSomatic Gene therapyGermline Gene therapyBy ApplicationGenetic DisordersNeurological DisorderOncologyCardiovascular DisordersDiabetes MellitusInfectious DiseasesHypertensionBy TechnologyEx vivo and in vivo gene therapyPhysical methodsChemical methodsBy Type of VectorsViral vectorsRetroviral vectorsNonviral vectorsArtificial viral vectorsBy Geography:North AmericaEuropeAsia PacificRest of the World (ROW)Download Free Sample Report of Global Gene Therapy Market @ https://www.decisiondatabases.com/contact/download-sample-412The Global Gene Therapy Market has been exhibited in detail in the following chapters –Chapter 1 Gene Therapy Market PrefaceChapter 2 Executive SummaryChapter 3 Gene Therapy Industry AnalysisChapter 4 Gene Therapy Market Value Chain AnalysisChapter 5 Gene Therapy Market Analysis By TypeChapter 6 Gene Therapy Market Analysis By ApplicationChapter 7 Gene Therapy Market Analysis By TechnologyChapter 8 Gene Therapy Market Analysis By Type of VectorsChapter 9 Gene Therapy Market Analysis By GeographyChapter 10 Competitive Landscape Of Gene Therapy CompaniesChapter 11 Company Profiles Of Gene Therapy IndustryPurchase the complete Global Gene Therapy Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-412Other Reports by DecisionDatabases.com:Global Plasma Therapy Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Oxygen Therapy Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Home Infusion Therapy Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
The Global Gene Therapy Market Report, with its deep industry analysis of the market, estimates the market size bifurcated into segments and regions.
The Gene Therapy market share and growth, trends estimated at the end of 2027 give a fair idea of the new opportunities coming up in the market.
The detailed key player's profile and market share analysis give a better understanding of the competitors and their business strategies.Base Year: 2020Estimated Year: 2021Forecast Till: 2027The report classifies the market into different segments based on type and product.
These segments are studied in detail, incorporating the market estimates and forecasts at regional and country levels.
The segment analysis is helpful in understanding the growth areas and potential opportunities of the market.Get | Download FREE Sample Report of Global Gene Therapy Market @ https://www.decisiondatabases.com/contact/download-sample-412A special section is dedicated to the analysis of the impact of the COVID-19 pandemic on the growth of the Gene Therapy market.
The impact is closely studied in terms of production, import, export, and supply.The report covers the complete competitive landscape of the Worldwide Gene Therapy market with company profiles of key players such as:AnGes MG, IncArk TherapeuticsCeregene, IncCobra BiologicsGenVec, IncGenzyme CorporationVical, IncOxford BioMedicaBioSante PharmaceuticalsShenzhen SiBiono GeneTech Co., LtdTransgeneWant to add more Company Profiles to the Report?
The Global PVC Window Profile Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved.
The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.The report classifies the market into different segments based on type and application.
These segments are studied in detail incorporating the market estimates and forecasts at regional and country level.
The segment analysis is useful in understanding the growth areas and probable opportunities of the market.Final Report will cover the impact of COVID-19 on this industry.Browse the complete Global PVC Window Profile Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/53045-pvc-window-profile-market-reportThe report also covers the complete competitive landscape of the global PVC Window Profile market with company profiles of key players such as:Alphacan SpAAluplast GmbHDeceuninckEpwin GroupEurocellPiva GroupProfine GroupRehauSalamanderSchucoVEKASEGMENTATIONS IN THE REPORT:By TypeTurn & Tilt WindowsSliding WindowCasement WindowOthersBy ApplicationResidentialCommercialBy Geography:North America (NA) – US, Canada, and MexicoEurope (EU) – UK, Germany, France, Italy, Russia, Spain & Rest of EuropeAsia-Pacific (APAC) – China, India, Japan, South Korea, Australia & Rest of APACLatin America (LA) – Brazil, Argentina, Peru, Chile & Rest of Latin AmericaMiddle East and Africa (MEA) – Saudi Arabia, UAE, Israel, South AfricaDownload Free Sample Report of Global PVC Window Profile Market @ https://www.decisiondatabases.com/contact/download-sample-53045The Global PVC Window Profile Market has been exhibited in detail in the following chapters –Chapter 1 PVC Window Profile Market PrefaceChapter 2 Executive SummaryChapter 3 PVC Window Profile Industry AnalysisChapter 4 PVC Window Profile Market Value Chain AnalysisChapter 5 PVC Window Profile Market Analysis By TypeChapter 6 PVC Window Profile Market Analysis By ApplicationChapter 7 PVC Window Profile Market Analysis By GeographyChapter 8 Competitive Landscape Of PVC Window Profile CompaniesChapter 9 Company Profiles Of PVC Window Profile IndustryPurchase the complete Global PVC Window Profile Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-53045Other Reports by DecisionDatabases.com:Global PVC Modifier Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Polyvinyl Chloride (PVC) Resins Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Polyvinyl Chloride (PVC) Films Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
The Global Polyvinyl Alcohol Fibers Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved.
The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.The report classifies the market into different segments based on product type and application.
These segments are studied in detail incorporating the market estimates and forecasts at regional and country level.
The segment analysis is useful in understanding the growth areas and probable opportunities of the market.Final Report will cover the impact of COVID-19 on this industry.Browse the complete Global Polyvinyl Alcohol Fibers Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/52885-polyvinyl-alcohol-fibers-market-reportThe report also covers the complete competitive landscape of the global Polyvinyl Alcohol Fibers market with company profiles of key players such as:Anhui Wanwei Group Co., Ltd.E.
I. du Pont de Nemours and CompanyEastman Chemical CompanyKuraray Co. Ltd.Nippon Synthetic Chemical Industry Co.Sekisui Chemical Co. Ltd.Sinopec Sichuan VinylonSEGMENTATIONS IN THE REPORT:By Product TypeFilament FiberStapleOtherBy ApplicationCement AdditivesTextileNon-Woven FabricBy Geography:North America (NA) – US, Canada, and MexicoEurope (EU) – UK, Germany, France, Italy, Russia, Spain & Rest of EuropeAsia-Pacific (APAC) – China, India, Japan, South Korea, Australia & Rest of APACLatin America (LA) – Brazil, Argentina, Peru, Chile & Rest of Latin AmericaMiddle East and Africa (MEA) – Saudi Arabia, UAE, Israel, South AfricaDownload Free Sample Report of Global Polyvinyl Alcohol Fibers Market @ https://www.decisiondatabases.com/contact/download-sample-52885The Global Polyvinyl Alcohol Fibers Market has been exhibited in detail in the following chapters –Chapter 1 Polyvinyl Alcohol Fibers Market PrefaceChapter 2 Executive SummaryChapter 3 Polyvinyl Alcohol Fibers Industry AnalysisChapter 4 Polyvinyl Alcohol Fibers Market Value Chain AnalysisChapter 5 Polyvinyl Alcohol Fibers Market Analysis By Product TypeChapter 6 Polyvinyl Alcohol Fibers Market Analysis By ApplicationChapter 7 Polyvinyl Alcohol Fibers Market Analysis By GeographyChapter 8 Competitive Landscape Of Polyvinyl Alcohol Fibers CompaniesChapter 9 Company Profiles Of Polyvinyl Alcohol Fibers IndustryPurchase the complete Global Polyvinyl Alcohol Fibers Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-52885Other Reports by DecisionDatabases.com:Global Nanofibers Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Glass Fibers Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Optical Fibers Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
According to a research report "Cognitive Assessment and Training Market by Assessment Type (Pen- and Paper-Based, Hosted, Biometrics), Component, Application (Clinical Trial, Screening & Diagnostics, Brain Training, Academic Research), Vertical, and Region - Global Forecast to 2021", published by MarketsandMarkets, the cognitive assessment and training market size is expected to grow from USD 1.98 Billion in 2016 to USD 8.06 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 32.3%.Browse 63 market data tables and 47 figures spread through 150 pages and in-depth TOC on "Cognitive Assessment and Training Market - Global Forecast to 2021"The major forces driving this market are aging global population, increasing awareness about brain fitness, and advancements in technology.
The growing market for cognitive solutions and increasing demand for brain training by next-generation tech-savvy population are contributing to the growth of the cognitive assessment and training market.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1039Clinical trials in terms of application is expected to hold the largest market share in the cognitive assessment and training market during the forecast periodClinical trials are mainly used to identify, measure, or monitor cognitive impairments and cognitive changes.
The assessment of cognitive functions is an integral part of decision-making during clinical drug development, as certain drugs can have an impact on the cognitive capabilities of the brain.
The market is expected to contribute the highest revenue for vendors offering clinical trials.Education vertical is expected to grow at the highest CAGR in the marketCognitive assessment solutions and services are used in the education vertical for screening prospective candidates for schools or colleges.
The leading cognitive assessment and training vendors for this vertical are Pearson Assessment and CogniFit.North America is expected to contribute to the largest market share and Asia-Pacific to grow at the highest CAGRNorth America is expected to hold the largest market share and to dominate the cognitive assessment and training market from 2016 to 2021, due to the increasing awareness among population about adopting medication for cognitive diseases.
The new generation in this region is more concerned toward the benefits of cognitive training, which is not just limited to patients with cognitive dysfunctions.
